Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Oct;45(10):907–909. doi: 10.1136/jcp.45.10.907

Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards.

S P Parker 1, W D Cubitt 1
PMCID: PMC495064  PMID: 1430261

Abstract

AIMS: To determine whether the Eiken particle agglutination test could be modified to make it sufficiently sensitive to screen blood samples collected on Guthrie cards for the presence of antibodies to Toxoplasma gondii; to evaluate the specificity of the modified system; and to compare seroepidemiological data on the prevalence of T gondii in pregnant women. METHODS: Simulated dried blood spots were prepared from sera from pregnant women booking for antenatal care. Eluates from the simulated dried blood spot cards and sera were tested in parallel using the modified test (1 in 5 dilution of latex) and the standard assay (neat latex particles) and endpoints determined. Guthrie card eluates, from neonates in three Thames regions, were then tested using the modified test. RESULTS: The modified test produced a 4.21-fold increase in antibody titre in 85 sera when tested in parallel with the standard test. Eluates of 168/170 from simulated dried blood spots derived from seropositive patients gave a positive result in the modified test. The two eluates which gave a negative result were derived from patients with an equivocal titre of 1/16 in the standard serum test. Of the eluates derived from serum negative patients all 103 were negative at a dilution of 1 in 4 in the modified test. The seroprevalence of antibodies to T gondii in pregnancy was 21.8% using the standard test. A similar value of 20.5% was obtained when dried blood spots from neonates in a similar region of London were tested by the modified test. CONCLUSIONS: The modified Eiken Toxo-reagent test is sensitive, simple, and economic for screening large numbers of dried blood spots. The procedure could be easily semiautomated and the technique applied to the mass screening of neonatal blood samples collected on Guthrie cards to determine the seroprevalence of T gondii in pregnant women.

Full text

PDF
907

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E., Parker S., Berry T., Holland F. J., Davison C. F., Cubitt D., Hjelm M., Wilcox A. H., Hudson C. N., Briggs M. Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet. 1991 Jun 29;337(8757):1562–1565. doi: 10.1016/0140-6736(91)93260-g. [DOI] [PubMed] [Google Scholar]
  2. Ades A. E., Peckham C. S., Dale G. E., Best J. M., Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health. 1989 Mar;43(1):53–60. doi: 10.1136/jech.43.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balfour A. H., Fleck D. G., Hughes H. P., Sharp D. Comparative study of three tests (dye test, indirect haemagglutination test, latex agglutination test) for the detection of antibodies to Toxoplasma gondii in human sera. J Clin Pathol. 1982 Feb;35(2):228–232. doi: 10.1136/jcp.35.2.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barbara J. A., Salker R., Challis P., Contreras M. Gelatin particle agglutination assay for HIV antibodies: a rapid, economical modification with increased sensitivity. Med Lab Sci. 1989 Apr;46(2):135–140. [PubMed] [Google Scholar]
  5. Cubitt W. D., Ades A. E., Peckham C. S. Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol. 1992 May;45(5):435–438. doi: 10.1136/jcp.45.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Desmonts G., Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N Y Acad Med. 1974 Feb;50(2):146–159. [PMC free article] [PubMed] [Google Scholar]
  7. Fleck D. G. Annotation: Diagnosis of toxoplasmosis. J Clin Pathol. 1989 Feb;42(2):191–193. doi: 10.1136/jcp.42.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Forsgren M., Gille E., Ljungström I., Nokes D. J. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet. 1991 Jun 8;337(8754):1413–1414. doi: 10.1016/0140-6736(91)93095-q. [DOI] [PubMed] [Google Scholar]
  9. Foulon W., Naessens A., Volckaert M., Lauwers S., Amy J. J. Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol. 1984 May;91(5):419–423. doi: 10.1111/j.1471-0528.1984.tb04777.x. [DOI] [PubMed] [Google Scholar]
  10. Hoff R., Berardi V. P., Weiblen B. J., Mahoney-Trout L., Mitchell M. L., Grady G. F. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med. 1988 Mar 3;318(9):525–530. doi: 10.1056/NEJM198803033180901. [DOI] [PubMed] [Google Scholar]
  11. Johnson J., Duffy K., New L., Holliman R. E., Chessum B. S., Fleck D. G. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol. 1989 May;42(5):536–541. doi: 10.1136/jcp.42.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Joss A. W., Chatterton J. M., Ho-Yen D. O. Congenital toxoplasmosis: to screen or not to screen? Public Health. 1990 Jan;104(1):9–20. doi: 10.1016/s0033-3506(05)80340-3. [DOI] [PubMed] [Google Scholar]
  13. Lappalainen M., Koskela P., Hedman K., Teramo K., Ammälä P., Hiilesmaa V., Koskiniemi M. Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis. 1992;24(1):97–104. doi: 10.3109/00365549209048407. [DOI] [PubMed] [Google Scholar]
  14. Peckham C. S., Chin K. S., Coleman J. C., Henderson K., Hurley R., Preece P. M. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet. 1983 Jun 18;1(8338):1352–1355. doi: 10.1016/s0140-6736(83)92138-4. [DOI] [PubMed] [Google Scholar]
  15. Peckham C. S., Tedder R. S., Briggs M., Ades A. E., Hjelm M., Wilcox A. H., Parra-Mejia N., O'Connor C. Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet. 1990 Mar 3;335(8688):516–519. doi: 10.1016/0140-6736(90)90746-r. [DOI] [PubMed] [Google Scholar]
  16. Tappin D. M., Girdwood R. W., Follett E. A., Kennedy R., Brown A. J., Cockburn F. Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet. 1991 Jun 29;337(8757):1565–1567. doi: 10.1016/0140-6736(91)93261-7. [DOI] [PubMed] [Google Scholar]
  17. Walker J., Nokes D. J., Jennings R. Longitudinal study of Toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect. 1992 Feb;108(1):99–106. doi: 10.1017/s0950268800049542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. van der Veen J., Polak M. F. Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection. J Hyg (Lond) 1980 Oct;85(2):165–174. doi: 10.1017/s0022172400063191. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES